Cardiovascular Health

These individuals, who were also more likely to require treatment in the intensive care unit, should get their vaccines and booster shots, investigators say.

The risk of death from CVD was approximately 15% lower for those with the highest vegetable intake compared to the lowest vegetable intake.

At week 4, there was about a 61.6% decrease for individuals with hypercholesterolemia who do not attain low-density lipoprotein cholesterol and/or are intolerant to other lipid-lowering drugs.

The researchers aimed to identify the factors that may influence the risk of statin intolerance.

The treatment for hypertrophic cardiomyopathy met its primary endpoint at week 6 in the phase 3 VALOR-HCM trial, the pharmaceutical company says.

Those with the disorder during gestation and who were examined 2 to 7-years after delivery had a more than 3-fold increased risk for incident high blood pressure, results of the analysis show.

This Valentine’s Day, pharmacists can remind patients that they may not need to feel guilty when they indulge in a small piece of chocolate.

New analysis shows the substitution would cut costs by $600 million in the United States annually.

American Heart Month is another example of the essential and valuable position that pharmacists hold in improving health care outcomes and optimizing patient-centered care.

Edoxaban (Savaysa) can reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Taking appropriate doses of vitamins and minerals may aid in lowering the risk of cardiovascular disease.

Lack of immediate results, cultural barriers, and high costs lead many to gamble with their cardiovascular health, study results show.

Following the first 3 days after a COVID-19 diagnosis, the risk of stroke quickly decreased.

Although the researchers were able to find an association between a heart attack and faster cognitive decline, the findings did not establish that a heart attack directly causes cognitive decline.

Investigators say more research is needed to better define the etiological sex differences in young adults and the contributions of nontraditional risk factors.

Preliminary research results show that immigrants from Africa have lower rates of CVD and stroke.

Investigators find that a small protein cell glucagon-like peptide-1 (GLP-1) couples the body’s control of blood sugar and BP.

Although men are more likely than women to be admitted for a hypertensive crisis, women have similar hospital mortality rates.

The men were assessed for neuroticism—or the tendency to interpret situations as stressful, threatening, or overwhelming—and worry levels through 2 mail-in surveys.

Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran (Leqvio; Novartis), discusses major trends in the atherosclerotic cardiovascular disease and LDL-C management treatment landscape this year.

Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran (Leqvio; Novartis), discusses projections for inclisiran’s use in clinical and pharmacy settings.

Some study limitations include that follow-up data were missing for some patients who dropped out of the study during the follow-up stages and the timing of the follow-up echocardiograms were random and driven by preference versus standard protocol.

New study results show that there are more incidences of this inflammation of the heart muscle related to not being vaccinated than there are to the vaccine itself.

The research team conducted a systematic review to collect the available published evidence on the topic and then combined the results using a process called meta-analysis.

Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran (Leqvio; Novartis), discusses the burden of ASCVD in the country today.

In a presidential advisory, the American Heart Association says that individuals thought to be having an allergic response to the injection may instead by experiencing a cardiac reaction.

Study results demonstrate that ProBiotix’s probiotic strain can significantly reduce low-density lipoprotein levels.

Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran (Leqvio; Novartis), discussed inclisiran’s mechanism of action and how it supports LDL-C management for patients with ASCVD.

Norman Lepor, MD, a cardiologist and clinical investigator in the phase 3 clinical program for inclisiran, discussed the trial results assessing the efficacy and safety of inclisiran for patients with atherosclerotic cardiovascular disease.

Olive oil consumption increased from 1.6 grams per day in 1990 to approximately 4 grams per day in 2010.